Stock VEN VENTAS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Ventas, Inc. Deutsche Boerse AG

Equities

VEN

US92276F1003

Market Closed - Deutsche Boerse AG
Other stock markets
 11:38:00 31/05/2024 am IST 		5-day change 1st Jan Change
45.05 EUR +3.97% Intraday chart for Ventas, Inc. +3.68% -0.86%
30/05 Wells Fargo Adjusts Price Target on Ventas to $49 From $46 MT
29/05 JPMorgan Adjusts Price Target on Ventas to $50 From $48 MT

Summary

  • Overall, the company has poor fundamentals for a medium to long-term investment strategy.

Strengths

  • The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
  • Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
  • For the past twelve months, EPS forecast has been revised upwards.
  • Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
  • Over the past twelve months, analysts' opinions have been strongly revised upwards.

Weaknesses

  • Low profitability weakens the company.
  • The company is in a hindered financial situation with significant debt and rather low EBITDA levels.
  • The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 2586.72 times its estimated earnings per share for the ongoing year.
  • The company's "enterprise value to sales" ratio is among the highest in the world.
  • For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
  • Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
  • Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.

Ratings chart - Surperformance

Sector: Specialized REITs

1st Jan change Capi. Investor Rating ESG Refinitiv
VENTAS, INC. Stock Ventas, Inc.
-0.86% 20.31B -
WELLTOWER INC. Stock Welltower Inc.
+14.97% 61.99B
A-
HEALTHPEAK PROPERTIES, INC. Stock Healthpeak Properties, Inc.
+0.51% 14.01B
A
OMEGA HEALTHCARE INVESTORS, INC. Stock Omega Healthcare Investors, Inc.
+5.45% 7.99B
B
HEALTHCARE REALTY TRUST INCORPORATED Stock Healthcare Realty Trust Incorporated
-9.17% 6.14B
B-
CARETRUST REIT, INC. Stock CareTrust REIT, Inc.
+14.32% 3.63B
C-
SABRA HEALTH CARE REIT, INC. Stock Sabra Health Care REIT, Inc.
+2.24% 3.38B
C+
MEDICAL PROPERTIES TRUST, INC. Stock Medical Properties Trust, Inc.
+9.16% 3.22B
C
AEDIFICA SA Stock Aedifica SA
-6.13% 3.08B
B+
NATIONAL HEALTH INVESTORS, INC. Stock National Health Investors, Inc.
+18.32% 2.87B
C-
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
-
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. VTR Stock
  4. VEN Stock
  5. Ratings Ventas, Inc.